Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, and IBM announced a collaboration in which Moderna will investigate next-generation technologies such as quantum computing and artificial....
The World Health Organisation (WHO) has released three online resources to help countries improve the execution of NTD programmes: an interactive dashboard, an online training course, and a mobile application. The World Health Organisation (WHO)...
US CDC Approves Second Omicron-Updated COVID Booster For Adults. The agency's decision follows the FDA's approval on Tuesday of a second dose of Omicron-updated booster for the specified high-risk population.
Marksans Pharma Limited, an Indian pharmaceutical business, has completed the acquisition of a production facility from Tevapharm India, according to an exchange filing. The deal was first announced in October 2022...
Motherhood Hospitals, which operates 21 hospitals in ten cities, has implemented a novel remote patient monitoring technology and system to provide virtual life-saving neonatal care to newborns admitted to nursing homes and hospitals in semi-urban...
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has signed a manufacturing collaboration agreement with Cook MyoSite, Inc. (Cook MyoSite) to facilitate Chemistry,...
Mankind Pharma, the creator of top-selling condom brand Manforce Condoms and funded by private equity firm ChrysCapital, has set the share price band for its initial public offering at Rs 1,026-1,080 per share, valuing the company at Rs 43,264....
Siemens Healthineers today opened a new manufacturing facility in Bengaluru for Magnetic Resonance Imaging machines. MAGNETOM Free.Star, a disruptively simple approach to high-quality MRI, will be manufactured in India at the moment....
Nigeria granted provisional approval to Oxford University's R21 malaria vaccine on Monday, becoming the second country to do so after Ghana last week. The approvals are unusual in that they came before the vaccine's final-stage trial data was...
ATMA Journey Centres Inc. (ATMA), Canada's leading psychedelic-assisted therapy training provider, announced that it has submitted to Health Canada a N500 3,4-Methylenedioxymethamphetamine (MDMA) phase II Clinical Trial Application (CTA), which...
, CDSCO.jpg)
.jpg)